The purpose of this study is to compare the racial differences in treatment and @entity1349 ( @entity1349 ) of @entity2675 ( @entity2675 ) @entity1 . Data were extracted from the NCI SEER database that included population-based registries from 1988 to 2010 and analyzed using SPSS 20.0. 4,279 @entity2675 @entity1 were identified. 3,266 (76.3%) @entity1 were White, 552 (12.9%) Black, 246 (5.7%) Hispanic, and 215 (5.0%) Asian. Black @entity1 were more likely to be diagnosed at younger age (P < 0.001), have advanced stage disease (P = 0.001), and be unmarried (P < 0.001) and less likely to undergo lymph node dissection (P = 0.006). When stratified by stage, there was no difference in receipt of primary treatment by race. The 5-year @entity1349 for White, Black, Hispanic, and Asian races was 73.8%, 66.3%, 74.0%, and 85.3% (P < 0.001). This significant worse 5-year @entity1349 for Blacks persisted regardless of age, @entity5 , and grade 2 or 3 disease. On multivariate analysis, Black race was a significant independent prognostic factor for worse @entity1349 . Blacks were less likely to receive lymph node dissection of which @entity1 may derive benefit, though we did not observe receipt of primary treatment, after stratifying for disease stage, to be an underlying factor contributing to racial outcome differences.

The impact of race in @entity2675 treatment and outcome in the United States: a population-based analysis of 4,279 XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['stage II or III disease'] @entity2675 :: ('MESH:D018567', 'Disease') :: ['MBC', 'male breast cancer'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity1 :: (9606,Species) :: ['patients']
